ACT-335827 [1354039-86-3]

MedChem Express

ACT-335827 [1354039-86-3]

10

1354039-86-3

Research Use Only

98.0

C31H38N2O5

518.64

ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders[1].

COC1=C(OC)C=CC(C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2[C@H](C4=CC=CC=C4)C(NC(C)C)=O)=C1

-20°C

12352200